Source comparison
Ipamorelin Dosing 100mcg 200mcg 300mcg: Research Comparison
100mcg 8–12 2–3 hours 50–60% Pulsatile GH studies, receptor sensitivity assays, protocols minimising total GH exposure Highest. Linear dose-response below saturation 200mcg 15–20 4–5 hours 70–80% Anabolic signalling research, metabolic studies, multi-dose dail
This comparison does not assign a generated winner or score.
- 100mcg
- 8–12
- 2–3 hours
- 50–60%
- Pulsatile GH studies, receptor sensitivity assays, protocols minimising total GH exposure
- Highest. Linear dose-response below saturation
- 200mcg
- 15–20
- 4–5 hours
- 70–80%
- Anabolic signalling research, metabolic studies, multi-dose daily protocols
- Optimal. Balances amplitude and duration without approaching ceiling
- 300mcg
- 18–22
- 5–6 hours
- 85–90%
- Ceiling effect studies, single-daily-dose protocols, comparison to GHRH co-administration
- Diminishing. 50% dose increase yields only 15–20% amplitude gain